UBS Group Increases Cardinal Health (NYSE:CAH) Price Target to $160.00

Cardinal Health (NYSE:CAH - Get Free Report) had its price target lifted by analysts at UBS Group from $150.00 to $160.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's price target indicates a potential upside of 6.96% from the stock's current price.

Several other equities analysts have also weighed in on CAH. TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Morgan Stanley raised their target price on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a report on Friday, January 31st. Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. Finally, Evercore ISI upgraded shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a research note on Tuesday, January 7th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $144.71.

Cardinal Health Stock Performance

NYSE CAH traded up $4.06 during mid-day trading on Tuesday, reaching $149.59. 3,365,880 shares of the stock were exchanged, compared to its average volume of 2,195,707. The stock has a market capitalization of $36.14 billion, a PE ratio of 27.91, a PEG ratio of 1.49 and a beta of 0.61. The business's fifty day simple moving average is $132.38 and its 200 day simple moving average is $124.98. Cardinal Health has a 1-year low of $93.17 and a 1-year high of $150.12.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The firm had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the prior year, the business posted $2.08 earnings per share. Cardinal Health's revenue for the quarter was up .0% compared to the same quarter last year. On average, analysts anticipate that Cardinal Health will post 7.95 EPS for the current year.

Institutional Trading of Cardinal Health

A number of institutional investors and hedge funds have recently modified their holdings of CAH. Mirae Asset Global Investments Co. Ltd. raised its stake in Cardinal Health by 35.2% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock worth $3,871,000 after acquiring an additional 8,471 shares during the period. CHURCHILL MANAGEMENT Corp raised its position in shares of Cardinal Health by 1.5% during the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock worth $28,435,000 after purchasing an additional 3,576 shares during the period. Consolidated Planning Corp boosted its position in Cardinal Health by 40.0% during the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock valued at $1,056,000 after purchasing an additional 2,552 shares during the period. Flputnam Investment Management Co. grew its stake in Cardinal Health by 1.8% during the 4th quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock worth $21,358,000 after buying an additional 3,148 shares during the last quarter. Finally, Patton Albertson Miller Group LLC acquired a new stake in Cardinal Health in the fourth quarter worth $258,000. 87.17% of the stock is owned by institutional investors and hedge funds.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.